Detalhe da pesquisa
1.
The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids.
J Hepatol
; 68(3): 441-448, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113909
2.
Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides.
Vaccines (Basel)
; 12(3)2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543900
3.
Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments.
Nanomedicine
; 9(1): 65-73, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22633898
4.
PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.
Microorganisms
; 11(4)2023 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37110395
5.
N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
J Hepatol
; 55(1): 29-37, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145866
6.
Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids.
PLoS Pathog
; 5(8): e1000563, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19714236
7.
Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer.
Microorganisms
; 9(5)2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067686
8.
Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA.
Microorganisms
; 9(2)2021 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573151
9.
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.
Genet Vaccines Ther
; 7: 7, 2009 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19505299
10.
The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response.
Cells
; 8(3)2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823485
11.
Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
Mol Immunol
; 43(12): 1941-52, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16442623
12.
Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.
J Immunol Res
; 2015: 762426, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26609538
13.
The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Mol Biotechnol
; 57(11-12): 1038-49, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446016
14.
HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells.
Viruses
; 7(6): 2745-70, 2015 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26035647
15.
Fine-mapping of the B-cell epitope domain at the N-terminus of the preS2 region of the hepatitis B surface antigen.
J Immunol Methods
; 260(1-2): 251-61, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11792393
16.
Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.
Clin Vaccine Immunol
; 20(11): 1719-28, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24006140
17.
A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.
PLoS One
; 8(9): e75938, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24086668
18.
Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
Clin Vaccine Immunol
; 17(6): 1027-33, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20410327
19.
High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Vaccine
; 26(16): 1972-81, 2008 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18343539
20.
Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.
Protein Expr Purif
; 50(1): 43-8, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16889980